CSL Limited
CSL
Clasificación en acciones
#363
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Precio por acción
$137.83
Capitalización bursátil
$66.14B
Cambio (1 día)
0.87%
Cambio (1 año)
-3.78%
País
AU
Comercio CSL Limited (CSL)
Categoría
Healthcare
Historial del precio de la acción de CSL Limited (CSL)
Precio más alto de cierre: $130.93 el 2026-10-01
Precio más bajo de cierre: $0.58 el 1994-05-01
Precio más bajo de cierre: $0.58 el 1994-05-01
Historial del precio de la acción de CSL Limited desde 1994 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | -11.03% |
| 2025 | -33.22% |
| 2024 | -3.40% |
| 2023 | -7.34% |
| 2022 | -5.55% |
| 2021 | -4.35% |
| 2020 | 13.64% |
| 2019 | 48.92% |
| 2018 | 19.64% |
| 2017 | 51.86% |
| 2016 | -2.99% |
| 2015 | 3.42% |
| 2014 | 17.66% |
| 2013 | 7.48% |
| 2012 | 72.89% |
| 2011 | -9.64% |
| 2010 | 27.38% |
| 2009 | 31.88% |
| 2008 | -30.73% |
| 2007 | 91.54% |
| 2006 | 59.34% |
| 2005 | 39.55% |
| 2004 | 69.88% |
| 2003 | 10.97% |
| 2002 | -54.53% |
| 2001 | 23.69% |
| 2000 | 47.80% |
| 1999 | 54.18% |
| 1998 | 35.94% |
| 1997 | 57.11% |
| 1996 | 56.41% |
| 1995 | 57.26% |
| 1994 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $890.85 | 9.42% |
NL
|
|
| $763.31 | 8.49% |
CH
|
|
| $263.80 | -7.32% |
BE
|
